title: Sensorineural deafness: An uncommon irreversible adverse effect of bortezomib.
authors.affiliation: Department of Hemato-Oncology, Apollo Hospitals, Bengaluru, Karnataka, India.
authors.forename: Parameswaran
authors.initials: P
authors.lastname: Anoop
authors.affiliation: Department of Hemato-Oncology, Apollo Hospitals, Bengaluru, Karnataka, India.
authors.forename: Channappa N
authors.initials: CN
authors.lastname: Patil
authors.affiliation: Department of Hemato-Oncology, Apollo Hospitals, Bengaluru, Karnataka, India.
authors.forename: Vaishnavi S
authors.initials: VS
authors.lastname: Joshi
authors.affiliation: Department of Hemato-Oncology, Apollo Hospitals, Bengaluru, Karnataka, India.
authors.forename: Poonam
authors.initials: P
authors.lastname: Maurya
authors.affiliation: Department of ENT, Apollo Hospitals, Bengaluru, Karnataka, India.
authors.forename: Pradeep
authors.initials: P
authors.lastname: Hosamani
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069286:Bortezomib / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D000069286:Bortezomib